8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Neurodegenerative Diseases in 1 studies
8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramezani, F | 1 |
| Salehian, S | 1 |
| Hosseinzadeh, S | 1 |
| Mahjour, Z | 1 |
| Babajani, T | 1 |
| Ghorbanian, D | 1 |
| Feizi, F | 1 |
| Pourbagher, R | 1 |
1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Neurodegenerative Diseases
| Article | Year |
|---|---|
Serotonin-1A receptor activation in the median raphe nucleus improves response learning-based strategy in 192IgG saporin-induced cognitive impairments.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antibodies, Monoclonal; Brain; Cholinergic Agents; | 2022 |